Glucose and fat levels in the blood decreased among obese adults with type 2 diabetes when they exercised after a meal… Jill Kanaley, PhD, of the department of nutrition and exercise physiology at the University of Missouri, said in a press release, “This study shows that it is not just …
Read More »‘Smart’ Insulin Holds Promise for Type 1 Diabetes Patients
A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes… Self-administered insulin is the most important therapeutic to provide control over blood glucose levels for patients with type 1 diabetes. However, standard insulin therapy introduces a …
Read More »Breastfeeding May Lower Risk of Type 1 Diabetes
A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes… The objective of this study was to determine the association of breast feeding duration with the risk of type 1 diabetes in genetically predisposed newborns. In addition, this study looked at …
Read More »Fatty Acids Can Be Marker for Type 2 Diabetes
High nonesterified fatty acids (NEFAs) show negative relationship to type 2 diabetes. But n-3 fatty acids (FAs) may protect against the disease… Chronically high nonesterified fatty acids (NEFAs) are a marker of metabolic dysfunction and likely increase risk of type 2 diabetes. By comparison, n-3 fatty acids (FAs) have been …
Read More »Quality Management in Diabetes Care
Using feedback and tailored support for clinicians, healthcare can be improved…
Read More »Even Without HTN, BP Meds Benefit Diabetes Patients
A new analysis indicates that people with type 2 diabetes are less likely to suffer myocardial infarctions, strokes, or early mortality when they take blood pressure medications — even if they don’t actually have hypertension…
Read More »Increased Cancer Risk Associated with Type 1 and Type 2 Diabetes
Why is cancer risk higher among diabetes patients?… Evidence indicates an increased risk of certain cancers among people with type 2 diabetes. Evidence for rarer cancers and for type 1 diabetes is limited. Australian researchers recently explored the excess risk of site-specific cancer incidence and mortality among people with type …
Read More »54 Drugs with Weight Changes
Researchers examined data from 257 randomized trials to find out which drugs cause weight loss… Researchers conducted a systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. MEDLINE, DARE, and the Cochrane Database of Systematic Reviews were searched to identify published …
Read More »Does Detemir Cross the Placenta in Women with Diabetes?
The relatively new long-acting insulin analog needs to be studied to determine its absorption pharmacokinetics… Insulin detemir (IDet) is a relatively new long-acting insulin analog that offers improved absorption pharmacokinetics and slower tissue distribution due to high plasma protein binding. As IDet is increasingly used for treatment of insulin-requiring diabetes, …
Read More »Keeping Blood Sugars Down May Delay Type 1 Diabetes Complications
Optimum HbA1c level yet to be determined… HbA1c is strongly related to the development of diabetes complications, but it is still controversial as to which HbA1c level to strive for in the treatment of type 1 diabetes. Swedish researchers evaluated HbA1c, followed from diagnosis, as a predictor of severe microvascular …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.